Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, August 18, 2026

Snapshot: Aug 18, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Tue, Aug 18, 2026 Broad Selloff High

Broad selloff crushed S&P 500 by 0.47% as tech and financials bore the brunt, though high-octane dispersion lifted healthcare and biotech gainers on individual catalysts.

55% Across-the-board equity decline with S&P 500 down 0.47%, Nasdaq Composite off 0.59%, and Russell 2500 hit hardest at -1.34%, marking a classic broad_selloff regime with fear moderately elevated as VIX climbed 8.9% to 15.8.
30% Extreme single-stock dispersion saw 50 gainers average +27% led by IPST (+83%), AIXC (+80%), and SLE (+78%), while 50 losers averaged -26% headed by SHOT (-90.5%) and LGCL (-83%), with healthcare capturing 32% of winners on clinical wins from AMLX, RCEL, and PBM.
15% Tech and Financial Services dominated the losers list with 26% and 21% share respectively, though healthcare's strong showing among gainers signals a sector rotation where biotech and healthcare equities rewarded positive Phase 3 trials, acquisitions, and regulatory milestones despite the macro headwind.

Healthcare drove 32% of gainers 5 names returned after long absences SKYH.WT · 4-day losers streak BANL · 3-day gainers streak AMLX — first appearance INACR — first appearance

Market Regime

Tue, Aug 18, 2026 Risk-On conf: medium macro · prototype

+25

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.8 p24 Drawdown-1.4% Held12d · established SinceAug 3

Top drivers: VIX percentile ▲ S&P vs 50d avg ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Tue, Aug 18, 2026 13

S&P 500

7,691.76

−36.44

-0.47%

Dow Jones

53,343.40

−448.45

-0.83%

NASDAQ Composite

26,289.71

−155.74

-0.59%

NASDAQ 100

29,490.96

−34.52

-0.12%

DJ US Total Market

76,217.68

−371.81

-0.49%

Russell 1000

4,192.72

−20.95

-0.50%

S&P MidCap 400

3,854.62

−27.77

-0.72%

Russell 2000

3,017.89

−9.23

-0.31%

Russell 2500

1,286.81

−17.54

-1.34%

Russell 3000

4,377.83

−21.51

-0.49%

Nasdaq Financial-100

7,570.44

−57.76

-0.76%

NIFTY 50

24,154.90

−281.05

-1.15%

VIX

15.84

+1.29

+8.87%

Biggest Gainers

Tue, Aug 18, 2026 50

IPST

Heritage Distilling Holding Company, Inc.Consumer Defensive

$15.93+$6.61

+83.0%

NASDAQ · Mkt cap $1.3 M

No news headlines were found in the last 48 hours, so the 83% gain cannot be attributed to a disclosed event. The move likely reflects either delayed news dissemination, a technical catalyst such as short covering, or undisclosed company developments.

Heritage Distilling Holding Company experienced an extraordinary 83% single-day gain with zero identifiable news coverage in the prior 48 hours according to the available Yahoo Finance RSS feed. This disconnect between price action and headline coverage is notable and suggests several possibilities. First, news may have broken but not yet propagated through major RSS feeds or there could be a lag in indexing. Second, the move could reflect technical factors—small-cap spirits companies sometimes trade with high volatility and may be subject to short squeezes or momentum trading, particularly if shares outstanding are limited. Third, the gain might result from a private development, earnings surprise, partnership announcement, or regulatory approval that has not yet been widely reported. Without corroborating headlines, we cannot definitively establish causation.

AIXC

Aixcrypto Holdings IncTechnology

$1.31+$0.58

+80.2%

TNON

Tenon Medical, Inc.Healthcare

$5.38+$3.88

+78.9%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours, so the 78.86% gain on TNON cannot be attributed to a specific announced event. The jump likely reflects either delayed market reaction to prior news, a technical or sentiment-driven move, or an untracked catalyst.

The absence of recent news headlines is striking given TNON's ranking as the third-biggest gainer for the day. A move of this magnitude in a medical device stock typically correlates with major corporate events: regulatory approvals, clinical trial results, acquisition news, earnings surprises, or significant contract wins. Since no such headlines appear in the Yahoo Finance feed from the past 48 hours, several possibilities emerge. First, the catalyst may predate the 48-hour window but only now be reflected in trading. Second, the move could be driven by technical factors, short covering, or retail sentiment rather than news-based fundamentals. Third, a material announcement may have been made through channels not captured in this headline feed, or may be awaiting official dissemination. Without visibility into Tenon Medical's specific business drivers, recent clinical or regulatory status, or shareholder structure, deeper analysis is constrained. Small-cap medical device stocks are occasionally subject to volatile moves tied to clinical developments or FDA feedback, but confirmation cannot be established here.

SLE

Super League Gaming IncCommunication Services

$5.25+$2.32

+77.9%

NASDAQ · Mkt cap $6.6 M

Japan's Metaplanet announced a major $132 million investment of 2,100 Bitcoin into Super League Gaming, which will be renamed Superplanet and trade under ticker SUPA, with Metaplanet gaining 95.7% ownership and board control.

The 77.85% single-day gain directly correlates with the August 18 announcement of Metaplanet's substantial capital injection and operational takeover. Metaplanet, described as the third-largest corporate holder of Bitcoin globally, is deploying a portion of its significant crypto treasury into Super League, effectively transforming it into a subsidiary. The deal represents both a substantial injection of liquidity into the previously smaller gaming media company and a major voting control shift, with Metaplanet appointing the chairman and board majority. The rebranding to Superplanet and ticker change to SUPA signal a fundamental restructuring. For a smaller-cap stock like SLE, this type of control transaction combined with Bitcoin-backed capital from a well-known international firm appears to have triggered significant investor interest, likely driven by both the capital infusion itself and perceived validation from an established crypto-treasury holder.

GNLN

Greenlane Holdings IncConsumer Defensive

$3.06+$1.09

+55.3%

NASDAQ · Mkt cap $1.9 M

No news headlines were found in the last 48 hours, so the 55% jump in GNLN appears driven by a catalyst outside the provided information sources, most likely a company announcement, analyst upgrade, or sector-wide movement not captured by Yahoo Finance RSS.

Greenlane Holdings is a cannabis and tobacco accessories distributor, a sector that can experience sharp moves on supply chain developments, retail partnerships, regulatory changes, or short-squeeze activity. A 55% single-day gain without accompanying news in major feeds suggests either a delayed press release not yet indexed, an after-hours or premarket announcement, internal corporate action (stock split, dividend, capital restructuring), or technical/short-covering momentum. The stock's position as a smaller-cap, often thinly traded name in a speculative sector makes it susceptible to both legitimate news-driven moves and liquidity-driven swings that may not always be immediately covered by mainstream financial news aggregators.

PSIG

PS International Group Ltd. Ordinary SharesIndustrials

$1.59+$0.51

+46.8%

NASDAQ · Mkt cap $31 M

No headlines were found in the last 48 hours for PSIG, so the 46.79% single-day jump lacks an identified news catalyst; the move could reflect a delayed announcement, technical bounce, or other market event not yet captured in the news feed.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to ground the explanation in a specific company announcement or market event. A jump of this magnitude for a NASDAQ-listed stock typically correlates with earnings surprises, contract wins, regulatory approvals, M&A activity, or significant guidance changes. In rare cases, a heavily shorted or thinly traded stock can experience a sharp rally from short covering or technical momentum, particularly if it had been oversold. Without access to real-time volume data, insider activity, or deeper news sources beyond the RSS feed provided, the actual trigger remains unclear. The stock's low price point ($1.59) suggests it may be a smaller-cap or distressed name that could be prone to volatile moves on relatively minor catalysts.

EURKR

Eureka Acquisition Corp Right

$0.43+$0.14

+46.6%

NASDAQ

No news was reported in the last 48 hours for EURKR, so the 46.55% gain likely reflects either technical momentum in a low-priced SPAC rights instrument, delayed news digestion, or market-moving developments not yet captured in the headlines provided.

Eureka Acquisition Corp Right is a SPAC rights unit, a security type that trades in lower price ranges and can be sensitive to small absolute price movements that translate to large percentage gains. The lack of any news headlines in the last 48 hours makes it impossible to point to a specific corporate event, merger announcement, or operational catalyst. Two plausible categories of cause are most likely: first, technical or short-squeeze dynamics common in low-priced SPAC instruments where thin liquidity can amplify intraday swings, and second, a material announcement or development that occurred but was not yet indexed in the Yahoo Finance RSS feed at the time of reporting. SPAC rights instruments can also spike on expectations tied to their underlying acquisition target's news or timelines, even when the direct security does not receive explicit coverage.

AMLX

Amylyx Pharmaceuticals, Inc.Healthcare

$35.11+$10.38

+42.4%

NASDAQ · Mkt cap $3.8 B

Amylyx surged 42.38% on positive Phase 3 trial results for avexitide showing 55% reduction in severe hypoglycemic events, combined with a $350 million capital raise announcement.

The stock's best day ever reflects a clear catalyst: Amylyx announced successful Phase 3 LUCIDITY trial data for avexitide, its GLP-1 receptor antagonist designed to treat post-bariatric hypoglycemia. The drug met its FDA-agreed primary endpoint and all secondary endpoints, demonstrating clinically meaningful efficacy. This de-risks the development pathway substantially, moving the company from clinical uncertainty toward potential commercialization. The company simultaneously announced a $350 million public offering to fund that commercialization. The rally reflects both the clinical validation and the signal that management is confident enough to raise capital and advance toward market. All headlines consistently point to this same event cluster occurring on August 18, 2026.

INACR

Indigo Acquisition Corp. Right

$0.14+$0.04

+39.7%

NASDAQ

No news headlines were found in the last 48 hours to explain the 39.72% surge in INACR. The move likely reflects either a delayed market reaction to an earlier announcement, technical trading activity in a low-priced security, or a rumor not yet captured in major news feeds.

Indigo Acquisition Corp. Right is a SPAC-related equity right, a security type that typically trades at low absolute prices and can experience outsized percentage moves on modest dollar volume swings. The absence of any headlines in the past two days combined with a significant one-day gain suggests the catalyst may predate the snapshot window, may be a minor corporate action not yet indexed by major news aggregators, or may stem from technical factors common to micro-cap and right securities such as short covering, algorithmic trading, or retail sentiment shifts. SPAC rights can also react to news affecting the underlying sponsor or target acquisition timeline, but no such information is available here. Without supporting news, the move remains unexplained by public information.

WEAV

Weave Communications, Inc.Healthcare

$7.29+$1.75

+31.6%

NYSE · Mkt cap $586 M

Weave Communications announced an acquisition by Francisco Partners on August 18, 2026, triggering a 31.59% stock surge as the market priced in the takeover bid value.

The headline evidence directly attributes the stock's jump to an acquisition announcement. Weave Communications, an AI-powered patient engagement and payments platform for healthcare practices, received and announced an attractive takeover bid from Francisco Partners on August 18, 2026. The timing alignment between the acquisition announcement and the intraday surge, combined with the explicit characterization of the bid as attractive, strongly supports that the market reacted positively to the deal terms. Takeover announcements typically drive substantial same-day gains when the bid price exceeds the pre-announcement trading level, which the 31.59% jump suggests occurred here. Without the full press release or deal terms, we cannot determine the exact acquisition price or deal structure, but the headline evidence is unambiguous about the catalyst.

BANL

CBL International Limited - Ordinary SharesEnergy

$13.57+$3.09

+29.5%

NASDAQ · Mkt cap $26 M

CBL International reported a return to profitability in H1 2026 with more than doubled gross profit, strong volume growth, and a $0.10 per share special cash dividend announced on August 18, driving the 29.48% surge.

The company's H1 2026 results released today demonstrate a clear operational turnaround. CBL International, a marine fuel services provider, swung back into profitability driven by strategic positioning around Middle East supply route shifts and disciplined expense management. The headline metrics are compelling: gross profit more than doubled year-over-year, volume growth was strong, and management announced a special cash dividend of $0.10 per share, signaling confidence in cash generation and shareholder returns. The timing of the announcement on market hours (13:45 UTC) directly preceded the intraday surge. Investors rewarded the combination of operational recovery, improved margins, and tangible capital return. The geopolitical backdrop (supply route volatility) appears to have benefited the company's positioning rather than harmed it, suggesting management executed well on their multi-year network investments.

SXTC

China SXT Pharmaceuticals IncHealthcare

$5.21+$1.19

+28.5%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours, so the cause of the 28.47% gain is unknown; it could reflect a delayed announcement, technical rebound, sector rotation, or retail trading activity.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for SXTC's strong 28.47% gain on August 18, 2026. China-focused biotech and pharmaceutical stocks can be volatile and responsive to several types of events that may not appear in major RSS feeds immediately: clinical trial announcements, regulatory approvals in China, partnerships or licensing deals, insider activity, or shifts in sentiment toward China equities more broadly. It is also possible the move reflects technical buying pressure following a prior decline, short covering, or retail trading interest. Without corroborating news or data on short interest and trading volume, attribution remains speculative.

TGL

Treasure Global Inc.Technology

$2.66+$0.79

+27.7%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours for TGL, so the 27.72% gain on August 18, 2026 cannot be attributed to a reported event. The move likely reflects technical or market-driven factors rather than company-specific news.

The absence of any news headlines in the Yahoo Finance RSS feed over the snapshot period means we cannot point to earnings, guidance, regulatory action, partnerships, or other corporate events as the cause of this significant one-day jump. TGL is a fintech and digital payments company (part of the Fintech Acquisition Corp ecosystem), so typical catalysts for this sector include regulatory approvals, expansion into new markets, payment volume surges, or valuation multiple shifts. The 27.72% intraday move could reflect delayed disclosure of company-specific developments not yet captured in headline feeds, technical trading patterns, options-related activity, or broad sector rotation. Without access to pre-market announcements, insider filings, or company press releases issued outside the RSS window, the true driver remains unclear.

PBM

Newcourt Acquisition CorpHealthcare

$4.43+$0.96

+26.7%

NASDAQ · Mkt cap $16 M

Psyence BioMed announced that the U.S. administration has taken action to accelerate ibogaine development, directly supporting the company's pharmaceutical platform, driving a 26.67% single-day gain.

The headline from August 18, 2026 indicates that Psyence BioMed received positive regulatory tailwinds when the U.S. administration signaled commitment to accelerating ibogaine development. The company framed this as validation of its existing pharmaceutical development and manufacturing platform built around this psychedelic compound. For a SPAC-stage or early-stage biotech, federal policy support for a therapeutic area in which the company is positioned can be a material catalyst, as it reduces regulatory uncertainty and suggests a clearer path to commercialization. The timing of the announcement on market hours and its immediate prominence in news feeds likely triggered buying pressure from investors seeking exposure to ibogaine as a therapeutic asset class.

MODD

Modular Medical, Inc.Healthcare

$3.01+$0.63

+26.5%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours for MODD, so the 26.47% gain cannot be tied to a specific announced catalyst; the move likely reflects technical trading, a delayed news release, or market gossip.

The absence of recent news headlines makes it difficult to pinpoint the exact cause of MODD's strong single-day gain. A medical device or modular healthcare company trading at $3.01 is typically a small-cap or micro-cap stock that can be subject to high volatility. Without confirmed reporting, the jump could stem from several sources: a clinical trial result or regulatory decision released outside the major news feeds tracked by Yahoo Finance, short-covering or technical breakout buying, sector rotation into healthcare, or unverified rumors circulating on social media or message boards. Modular Medical's low price point also makes it susceptible to momentum and retail trading activity. Until official news is confirmed, attributing this move to a specific business catalyst would be speculation.

RCEL

Avita Medical LtdHealthcare

$9.81+$2.08

+25.9%

NASDAQ · Mkt cap $320 M

Avita Medical surged 26% after announcing positive PermeaDerm study results showing 70% economic advantage over allograft, combined with raised 2026 revenue guidance and strong Q2 sequential growth momentum.

The stock's sharp gain appears directly tied to the August 18 announcement of positive clinical economics data for PermeaDerm, demonstrating meaningful cost advantage versus the competitive allograft standard of care. This achievement of a primary endpoint addresses a key commercial validation point for investors. The timing coincides with broader positive momentum, including the company's August 16 announcement of raised 2026 revenue guidance following Q2 results that showed 18% year-over-year growth and 13% sequential acceleration. Management also flagged a path to Q4 2025 cash flow breakeven, reducing burn-rate concerns. For a smaller medical device company trading at these price levels, clinical validation of economic advantage combined with accelerating revenue and profitability visibility typically triggers strong institutional and retail buying, especially if investor positioning had been cautious beforehand.

COPR.WT

$1.63+$0.33

+25.4%

SCTX

Scribe Therapeutics Inc.Healthcare

$26.96+$5.09

+24.3%

NASDAQ · Mkt cap $586 M

No relevant news about SCTX was provided; the +24.32% gain likely reflects a company-specific catalyst such as clinical trial results, regulatory approval, partnership announcement, or short covering, but the exact cause cannot be determined from available headlines.

The news feed provided contains only a reference to analyst calls on Norwegian Cruise and Duolingo, which are unrelated to Scribe Therapeutics. SCTX is a precision medicine and gene-editing company, and stocks in this sector typically move sharply on clinical data releases, FDA decisions, licensing deals, or capital raises. A single-day 24% jump of this magnitude in a biotech name usually signals a material company-specific event rather than broad market movement. Without access to SCTX-specific news, the most probable categories are positive clinical trial readout, regulatory approval, partnership or financing announcement, or technical short-squeeze activity. The rank as the 18th biggest gainer suggests this is a genuine intraday mover, not noise.

MSS

Maison Solutions Inc. - Class A Common StockConsumer Defensive

$1.55+$0.35

+24.1%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours, so the 24% gain likely reflects technical trading, a delayed announcement, or renewed retail interest rather than a specific corporate event.

The absence of recent news headlines makes it difficult to pinpoint a concrete catalyst for MSS's sharp 24% single-day jump. Micro-cap stocks like this one, trading at $1.55, are often subject to technical momentum, short covering, or delayed dissemination of information not yet captured in financial news feeds. The move could reflect a positive earnings surprise, contract award, or strategic update that has not yet been indexed by major news sources, or it could stem from retail attention driven by social media or message boards. Without accompanying headlines or knowledge of MSS's specific business fundamentals and float structure, the most honest assessment is that a real catalyst may exist but is not yet documented in the sources provided.

WINVR

WinVest Acquisition Corp.

$0.05+$0.01

+23.5%

NASDAQ

No news was found in the last 48 hours, so the 23.52% gain in WINVR stock appears driven by a factor outside the provided headlines, likely technical trading activity or delayed market reaction to an earlier announcement.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for today's jump. WINVR is a SPAC (special purpose acquisition company), a structure that typically attracts retail and technical traders. Price moves in thinly traded SPACs, especially at very low share prices like $0.05, can be amplified by modest volume shifts and are often more responsive to technical patterns, short covering, or retail trading momentum than to fundamentals. The stock's rank as the 20th biggest gainer suggests it was part of a broader retail trading wave rather than a company-specific event. Without current headlines, the most likely categories of catalyst are a delayed reaction to an older announcement, options-related technical trading, or pure speculation.

GRNQ

Greenpro Capital CorpIndustrials

$12.28+$2.24

+22.3%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 22.27% gain cannot be directly tied to a specific announcement or disclosed event. The jump is likely driven by technical trading, retail interest, a delayed news pickup, or market speculation.

GRNQ is a micro-cap fintech and blockchain-focused company, which typically exhibits high volatility and can be subject to technical rallies, short covering, or retail trading momentum without fundamental catalysts appearing in major news feeds. The absence of any Yahoo Finance headlines in the last 48 hours does not rule out private news flow, social media attention, or sector-wide sentiment shifts in cryptocurrency or fintech stocks that may not have broad press coverage yet. Micro-caps of this type can also gap on rumors, analyst upgrades, or delayed reporting of earlier announcements. Without substantive evidence of a specific catalyst, the move must be inferred as likely stemming from technical or sentiment-driven factors rather than fundamental news.

FCUV

Focus Universal, Inc.Technology

$7.80+$1.36

+21.0%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 21% gain likely stems from technical factors, delayed announcements, or market rumors not yet captured in major financial media.

Focus Universal experienced a significant 21% single-day jump to rank among the top 20 gainers on NASDAQ, yet no recent news headlines are available to explain the move. This disconnect between price action and reported news creates genuine uncertainty about the catalyst. For a micro-cap or small-cap stock like FCUV, typical drivers of such moves include: technical rebounds following oversold conditions, retail social media coordination, options-related gamma effects, or undisclosed corporate developments that have not yet reached major news aggregators. Without access to company press releases, SEC filings, or analyst notes filed after the RSS feed cutoff, we cannot identify a specific event. The absence of news does not rule out material corporate activity; it simply means the evidence is not currently available to confirm causation.

IMC

IMC Rare Earths LtdBasic Materials

$10.20+$1.78

+20.9%

NYSE · Mkt cap $1.1 B

No news headlines were found in the last 48 hours, so the 20.92% gain cannot be attributed to a specific disclosed event. Rare earth stocks can move sharply on commodity price swings, geopolitical supply concerns, or sector rotation, but without recent headlines the cause remains unclear.

IMC Rare Earths Ltd jumped over 20% with zero news coverage in the prior 48 hours. This disconnect between a large move and absent headlines suggests either a delayed market reaction to older news, a technical or sentiment-driven move, or an undisclosed event not yet picked up by major wire services. Rare earth companies are cyclical and sensitive to end-market demand signals, commodity pricing, and supply chain developments. The stock could have reacted to movement in rare earth element prices, broader sector rotation into materials, geopolitical developments affecting supply chains, or short covering. Without a news hook, however, any explanation is speculative. The stock's rank as number 23 gainer suggests sector-wide or market-wide momentum rather than firm-specific catalysts.

BIAF

bioAffinity Technologies, Inc. Healthcare

$0.47+$0.08

+20.8%

NASDAQ · Mkt cap $3.3 M

bioAffinity Technologies announced a nationwide federal healthcare distribution agreement with AvMEDICAL for its CyPath Lung diagnostic on August 18, which likely drove the 20.81% gain by expanding market access to government healthcare systems.

The company signed a distribution agreement with AvMEDICAL that grants CyPath Lung access to an established federal healthcare sales network. This represents a concrete commercial milestone for the diagnostic product, expanding its addressable market into government systems where AvMEDICAL already has established relationships. For a small-cap biotech diagnostic company trading at $0.47, securing a nationwide federal distribution channel is a material business development event that can justify significant one-day appreciation, particularly if investors view it as validation of the product and a path to meaningful revenue scaling. The timing of two nearly identical announcements within hours suggests coordinated company disclosure, typical of material corporate events.

DVLT

Datavault AI IncTechnology

$0.39+$0.07

+20.8%

NASDAQ · Mkt cap $253 M

Datavault AI announced a $94.5 million all-cash acquisition of CyberCatch on August 17, which likely drove the 20.81% gain as the market rewarded the strategic expansion move.

The most direct catalyst is the acquisition announcement disclosed on August 17 at 11:13 UTC, just before market close or into the next trading session. M&A announcements involving cash purchases of established cybersecurity firms (CyberCatch) by smaller AI-focused acquirers typically attract investor interest, particularly if the deal is perceived as strategically sound or accretive. The second news item about DataMeds AI, a separate company, appears unrelated to DVLT's move. Without visibility into deal structure details, growth assumptions, or analyst commentary on synergies, we cannot confirm whether the market viewed this as accretive or dilutive long-term; however, the timing of the announcement and magnitude of the one-day move suggest the market received it positively. The stock's rank as the 25th biggest gainer indicates broad market participation in the move rather than a narrow squeeze.

OBIO

Health Sciences Acquisitions Corporation 2Healthcare

$5.67+$0.96

+20.3%

NASDAQ · Mkt cap $334 M

No news headlines were found in the last 48 hours to explain OBIO's sharp 20% gain, so the driver remains unclear without additional context on SPAC developments or market dynamics.

Health Sciences Acquisitions Corporation 2 is a SPAC, a shell company typically formed to acquire a private operating company and take it public. No headlines appeared in the last 48 hours to pinpoint the catalyst for the 20% jump. SPACs can move sharply on several catalysts: announcement or progress toward a merger target, regulatory clearance for a pending deal, insider buying, changes in redemption dynamics ahead of a shareholder vote, or technical factors such as short covering if the stock trades with elevated short interest. Without news coverage, the move could also reflect delayed announcement of information that broke outside the covered news feed, a rumor circulating among traders, or pure technical momentum in a lower-volume SPAC name where small volumes can move prices significantly. The rank as 26 biggest gainer suggests it was notable volume activity, but the underlying reason is not evident from available headlines.

SAGT

SAGTEC GLOBAL LIMITED Ordinary sharesTechnology

$0.76+$0.12

+18.6%

NASDAQ · Mkt cap $13 M

Sagtec announced the official launch of its HALO AI platform and secured a $3 million purchase order for 1,500 AI food-serving robots from a Dubai distributor, marking a major commercialization milestone that likely drove the 18.56% gain.

The headline announces a concrete, material event: a named customer order worth $3 million for 1,500 units of a new product (HALO AI robots) into the Middle East market. This represents tangible revenue visibility and proof of commercial demand for Sagtec's AI robotics platform, moving the company from development stage toward large-scale deployment. For a small-cap stock trading near $0.76, a major purchase order from an international distributor is a significant de-risking event that justifies investor enthusiasm. The timing of the announcement on the same day as the price jump, combined with the specificity of the order details, strongly supports this as the causal factor. This is the type of catalyst that typically drives outsized moves in emerging robotics or AI companies.

KIDZ

Classover Holdings, Inc. Class B Common StockConsumer Defensive

$4.69+$0.76

+18.5%

LKSPR

Lake Superior Acquisition Corp. Rights - For Shares

$1.10+$0.17

+18.5%

NASDAQ

No news was reported in the last 48 hours, but LKSPR is a SPAC rights offering that may have gained on underlying SPAC warrant or common stock momentum, technical mean reversion, or retail interest in small-cap derivatives.

Yahoo Finance returned zero headlines for LKSPR in the past 48 hours, so the catalyst cannot be attributed to any specific company announcement, regulatory action, or deal news. LKSPR is a rights offering for Lake Superior Acquisition Corp., a special purpose acquisition vehicle structure. Rights offerings and SPAC-related securities often see outsized percentage moves on modest volume because the share price is already near par value, making percentage moves appear large in absolute terms. The 18.47% jump could reflect technical mean reversion, retail trading activity, correlation with broader SPAC sentiment, or a delayed reaction to news that may not yet be indexed by the RSS feed. Without headlines, attribution remains speculative.

EJH

E-Home Household Service Holdings LimitedConsumer Cyclical

$2.04+$0.35

+18.0%

NASDAQ · Mkt cap $6.6 M

No news headlines appeared in the last 48 hours for EJH, so the 18% gain on August 18 cannot be attributed to a disclosed catalyst. The move likely reflects technical trading, a delayed market reaction to an earlier announcement, or market rumor.

The absence of any Yahoo Finance headlines in the two days leading up to this snapshot is noteworthy for a stock posting an 18% single-day gain and ranking 30th among daily gainers. EJH is a Chinese household services company, a sector historically subject to significant technical volatility and retail trading interest. Without confirmed news, the jump could stem from several categories: a technical or short-covering event, delayed dissemination of an older announcement not yet indexed in the RSS feed, insider or regulatory developments not yet public, or unconfirmed market rumors. Chinese small-cap stocks on U.S. exchanges frequently exhibit outsized moves on thin volume or sentiment shifts rather than fundamental catalyst. The timing and magnitude suggest this warrants checking for simultaneous sector movements or regulatory updates to the company's home market that may not have reached Western news outlets yet.

AIAI

AIAI Holdings CorporationIndustrials

$5.92+$0.90

+17.9%

NASDAQ · Mkt cap $367 M

AIAI surged 17.93% likely on news of a $250MM initial annual EBITDA opportunity through M42's strategic teaming agreement announced August 17, combined with a shareholder letter from CEO Todd Furniss on August 18.

Two pieces of news arrived within 48 hours preceding the jump. On August 17, M42 LLC announced a Fairfax-Epirus teaming agreement expected to generate $250MM in initial annual EBITDA and free cash flow, with M42 explicitly exploring a strategic transaction with AIAI Holdings. This is material—a nine-figure EBITDA opportunity signals meaningful near-term revenue acceleration. The following day, CEO Todd Furniss issued a shareholder letter, which likely reinforced investor confidence or provided additional color on execution. Together, these announcements suggest either a pending transformational deal or a major business partnership that substantially improves the company's financial outlook. No negative news or guidance cuts were mentioned, supporting the positive sentiment.

ADGI

Adagio Therapeutics, Inc.

$0.87+$0.13

+17.2%

YDES

YD BIO LIMITEDHealthcare

$3.98+$0.58

+17.1%

NASDAQ · Mkt cap $317 M

No news headlines were found in the last 48 hours, so the 17% gain on YDES cannot be directly attributed to a specific disclosed catalyst. The move likely reflects either delayed market reaction to older news, technical trading, or untracked developments.

YD BIO LIMITED showed a notable 17% single-day gain while ranked 33rd among NASDAQ gainers, yet no relevant news headlines appeared in the last 48 hours. This disconnect suggests the catalyst either preceded the snapshot window, circulated through non-RSS channels, or arose from technical or sentiment-driven factors. Biotech stocks, particularly smaller-cap names, are sensitive to clinical trial announcements, regulatory decisions, partnership deals, and short-covering activity. Without headline confirmation, the move could reflect: (1) a delayed market reaction to news released earlier than the 48-hour window, (2) technical momentum or options-driven positioning, or (3) insider or institutional accumulation on unannounced developments. None of these can be confirmed from the available evidence.

PTLE

PTL LTDConsumer Cyclical

$7.95+$1.15

+16.9%

NASDAQ · Mkt cap $50 M

No news headlines were found in the last 48 hours for PTLE, so the 16.91% intraday gain likely reflects either a delayed market reaction to an untracked development, technical momentum, or speculative positioning rather than a confirmed corporate event.

The absence of any Yahoo Finance headlines in the past two days makes it difficult to anchor the move to a specific catalyst. PTLE gained over 16% on August 18, which is a material single-day jump that typically requires either earnings, guidance revision, deal news, regulatory approval, or significant sector momentum. Given no confirmed news, the most probable explanations are either a corporate announcement that has not yet filtered into the RSS feed used here, short-covering or technical breakout buying in a lower-liquidity name, or spillover bullish sentiment from the broader market or industry peers. Without access to press releases, SEC filings filed that day, or real-time social media discussion, the specific trigger remains unidentifiable from the available evidence.

EMISR

Emmis Acquisition Corp. Rights

$0.13+$0.02

+16.9%

NASDAQ

No news headlines were found in the last 48 hours, so the 16.91% gain is likely driven by technical trading activity, options activity, or other market dynamics affecting this thinly-traded rights security.

EMISR is a rights offering associated with Emmis Acquisition Corp., a blank-check acquisition vehicle. Rights offerings on SPAC-related securities are characteristically thin and low-volume, making them susceptible to outsized percentage moves on modest absolute share purchases or short covering. With no news catalyst identified in the provided headlines, the move is most plausibly explained by one of several inferences: a technical rebound from oversold conditions, options-driven hedging or expiration activity, modest retail buying interest in a low-priced security, or a delayed market reaction to an announcement that has not yet surfaced in the RSS feed. Rights securities also tend to see sporadic trading around key merger or extension deadlines. Without access to volume data, redemption news, or merger timing updates, we cannot isolate the specific driver, but the absence of negative news and the small absolute price change ($0.02 in a $0.13 stock) is consistent with normal volatility in micro-cap SPAC-related instruments rather than a fundamental event.

XOS

Xos, Inc.Industrials

$4.45+$0.66

+16.9%

NASDAQ · Mkt cap $41 M

Xos secured its first U.S. Air Force contract to deliver a prototype ruggedized energy storage system, marking the company's entry into the defense market. This contract win drove the 16.88% intraday gain following a 120% premarket surge.

The news headlines establish a concrete catalyst: Xos was selected by the U.S. Air Force Global Strike Command Rapid Capabilities Division through their 2026 Showcase to deliver a prototype ruggedized Xos Hub energy storage system for electrified support equipment and vehicles. This represents the company's first defense sector contract and signals validation of its technology in a new, potentially high-value market segment. For an electric commercial vehicle company, winning a U.S. Air Force contract carries significant strategic weight, suggesting both near-term revenue potential and long-term market expansion. The premarket surge of 120% indicates strong investor enthusiasm; the 16.88% close-of-day gain reflects some profit-taking from those premarket highs but sustained conviction in the news.

RENX

RenX Enterprises Corp.Real Estate

$1.87+$0.27

+16.6%

NASDAQ · Mkt cap $5.2 M

No headlines were found in the last 48 hours for RENX, so the 16.58% gain on August 18 cannot be attributed to any identified news catalyst. The move likely reflects technical trading, retail interest, or an undetected announcement outside the Yahoo Finance RSS feed.

The absence of recent news headlines is notable given the stock's significant single-day gain of over 16 percent, which placed it among the top 37 gainers on NASDAQ. For a micro-cap or thinly-traded stock like RENX trading at $1.87, such moves are sometimes driven by technical factors including short covering, momentum trading, or algorithmic rebalancing. Alternatively, the catalyst could be a material announcement that has not yet been indexed by Yahoo Finance's RSS feed, a private placement, a court ruling, or analyst coverage not captured in this snapshot. Without access to real-time company filings, press releases, or broker networks, it is impossible to pinpoint the specific driver.

GIAC

Gesher I Acquisition Corp.

$1.57+$0.22

+16.3%

AEI

Alset EHome International Inc.Real Estate

$1.76+$0.25

+16.2%

NASDAQ · Mkt cap $64 M

No news headlines were found in the last 48 hours, so the 16.23% gain on AEI likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or an unmonitored news event.

The absence of recent headlines makes direct causation impossible to establish. AEI is a micro-cap stock trading at $1.76, which typically exhibits higher volatility and can be more susceptible to technical rebounds, short covering, or investor sentiment shifts unrelated to fundamental news. Possible catalysts include a reversal of an earlier sell-off, accumulation by insiders or activist investors, social media interest, or a business announcement that did not reach major financial news wires. Without confirmed reporting on earnings, partnerships, product launches, or corporate actions, any explanation remains speculative. The stock's rank as the 39th largest gainer despite no recent news suggests either technical momentum or information asymmetry between retail and institutional players.

HAE

Haemonetics CorpHealthcare

$104.69+$14.42

+16.0%

NYSE · Mkt cap $4.7 B

HAE surged 16% on August 18, likely driven by a broad healthcare sector rally in late afternoon trading combined with possible positive analyst reassessment, though specific company-level catalysts are not documented in the available headlines.

The provided headlines indicate that healthcare stocks broadly climbed late Tuesday afternoon, with HAE's 16% gain ranking it 40 among daily gainers, suggesting sector-wide momentum rather than an isolated company event. The second headline references an analyst piece about unpopular stocks deserving a second chance, which could imply HAE was reassessed positively, but the headline does not confirm HAE is the specific stock discussed or provide details on the rationale. No earnings announcement, FDA action, guidance revision, or material contract award appears in the news feed. The magnitude of the move (nearly 16%) is substantial and could reflect either sector rotation into healthcare, short covering, or a delayed market reaction to a recent catalyst not captured in these particular headlines. Without company-specific news, the jump appears primarily driven by sector momentum or internal market forces.

LYEL

Lyell Immunopharma, Inc.Healthcare

$15.77+$2.17

+16.0%

NASDAQ · Mkt cap $386 M

No news was reported in the last 48 hours, so the +15.96% jump cannot be directly attributed to a disclosed catalyst. The move likely reflects either a delayed market reaction to an earlier announcement, technical trading, or sector momentum in biotech.

Lyell Immunopharma is a clinical-stage immunotherapy company focused on cell therapy development. The absence of news headlines in the window provided makes it impossible to pinpoint a specific catalyst. However, this stock type—early-stage biotech with high volatility—is prone to sharp moves on clinical trial updates, partnership announcements, FDA interactions, or sector-wide momentum shifts that may have occurred before the 48-hour window or been reported through channels outside the Yahoo Finance RSS feed. The +15.96% gain is substantial but not atypical for a micro-cap biotech stock. Without access to press releases, SEC filings, or conference activity during or just before this period, the precise trigger remains unknown.

CHRS

Coherus Biosciences IncHealthcare

$1.34+$0.18

+15.5%

NASDAQ · Mkt cap $205 M

Coherus announced a special dividend of contingent value rights tied to the sale of its remaining biosimilar assets, signaling completion of its transformation into a pure-play immuno-oncology company, which likely drove the 15.52% gain.

The company announced a special dividend consisting of biosimilar contingent value rights (CVRs) that will entitle shareholders to receive net proceeds from the sale of its remaining legacy biosimilar assets. This represents a milestone in Coherus's strategic pivot away from the lower-margin biosimilar business toward innovative immuno-oncology. The announcement frames this as completing the company's transformation into a fully integrated, innovative oncology-focused entity. Investors likely viewed this positively because it clarifies capital allocation, provides potential upside from asset sales, and signals management confidence in the oncology pipeline as the primary growth driver. The CVR structure also de-risks the portfolio by monetizing non-core assets while allowing shareholders to participate in those proceeds.

IVVD

Invivyd IncHealthcare

$0.86+$0.12

+15.4%

NASDAQ · Mkt cap $283 M

No news was reported in the last 48 hours, so the 15.43% gain likely stems from technical trading activity, short covering, or an untracked announcement outside the provided news feed.

The absence of any headlines in the last 48 hours makes it impossible to identify a specific fundamental catalyst for the move. Ivvyd is a clinical-stage biopharmaceutical company, and biotech stocks in this category are particularly sensitive to clinical trial updates, regulatory filings, partnership announcements, or guidance shifts. Given the lack of reported news, the move could reflect short covering in a thinly traded stock, technical breakout buying, or a material announcement that has not yet propagated to the Yahoo Finance RSS feed. Without additional context on recent insider activity, clinical trial status, or market sentiment shifts, we cannot definitively attribute the gain to any particular cause.

RETO

Reto Eco-solutions IncBasic Materials

$1.90+$0.25

+15.2%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours for RETO, so the 15.15% gain cannot be directly attributed to a disclosed catalyst. The move likely reflects technical trading, delayed news pickup, or micro-cap volatility.

The absence of recent news headlines makes direct attribution impossible. RETO is a small-cap eco-solutions company trading at $1.90, a price point and sector that can attract retail attention and technical trading activity. Possible explanations include: first, a technical or short-squeeze bounce in a thinly traded stock where modest buying pressure can create outsized percentage moves; second, a news event that has not yet been widely syndicated through major financial feeds; or third, sector-wide optimism in renewable or environmental solutions that lifted multiple names simultaneously. Without access to real-time order flow, message boards, or pre-market catalysts, the specific trigger remains unknown.

ABLV

Able View Global Inc. - Class B Ordinary SharesConsumer Cyclical

$0.84+$0.10

+14.4%

NASDAQ · Mkt cap $41 M

No news headlines were found in the last 48 hours, so the 14.37% intraday gain cannot be attributed to a specific announced event; the move likely reflects technical trading, short covering, or undisclosed news flow.

The absence of any recent news headlines for ABLV makes it impossible to identify a concrete catalyst for today's 14.37% jump. Given that ABLV is a micro-cap stock trading at $0.84 with relatively low liquidity typical of penny stocks and small-cap equities, this kind of sharp move can occur from several sources: technical bounces after oversold conditions, short-squeeze dynamics if significant short interest exists, options-driven volatility around expiration dates, or general momentum trading in volatile small-cap names. It is also possible that material news was released but not yet indexed by the RSS feed, or that the move reflects accumulation based on a private development not yet public. Without access to the actual market depth, short interest data, or proprietary news feeds, the specific driver remains unknown.

UUU

Universal Security Instruments IncIndustrials

$4.50+$0.57

+14.4%

NYSE · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 14.36% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, delayed coverage of an earlier event, or market rumors not yet captured in headline feeds.

Universal Security Instruments Inc (UUU) jumped 14.36% to rank 46th among daily gainers, yet zero news headlines appeared in the Yahoo Finance RSS feed over the past 48 hours. This disconnect between price action and available news is not uncommon for lower-capitalization or lower-coverage stocks. Possible explanations include: first, a technical or short-squeeze dynamic where algorithmic or retail buying pressure accelerated the move independent of fundamentals; second, an announcement or development that occurred just outside the 48-hour window or on a wire service not yet indexed by Yahoo's feed; third, commentary or rumors circulating on social media or trading forums that preceded formal press release distribution. Without access to intraday order flow, insider trading data, or direct company communications, the actual catalyst remains unconfirmed.

FSHPR

Flag Ship Acquisition Corporation

$0.07+$0.01

+14.3%

NASDAQ

No news headlines were found in the last 48 hours. The 14.29% gain on FSHPR, a blank-check company trading at $0.07, likely reflects either technical trading in a low-price stock or unconfirmed market rumors not yet captured in major news feeds.

FSHPR is a special purpose acquisition company (SPAC) with an extremely low stock price of $0.07, which makes it susceptible to outsized percentage moves on modest absolute dollar volume or small shifts in investor sentiment. The absence of any news in the last 48 hours means the jump cannot be attributed to reported earnings, guidance changes, merger announcements, or regulatory actions. For a SPAC at this price level, typical catalysts include merger deal announcements, insider buying signals, or technical breakouts that attract retail attention. Alternatively, the move could reflect a delayed market reaction to news from slightly earlier than the 48-hour window, or rumors circulating in less-formal channels that have not yet reached major news aggregators. Without substantive headlines or corporate structure insights, determining the specific cause remains speculative.

FLUX

Flux Power Holdings, Inc.Industrials

$0.74+$0.09

+14.1%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 14.08% gain in FLUX stock cannot be attributed to a specific announced event. The move likely reflects technical trading, options activity, or unindexed market sentiment.

The absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to an earnings release, product announcement, partnership, or guidance change as the driver. Flux Power Holdings is a small-cap battery and power management company, and stocks in this category can experience sharp moves on relatively modest volume or delayed news dissemination if major outlets have not yet picked up a story. Other plausible but unverified causes include short covering, retail options positioning, sector rotation into energy storage, or a broader micromarket technical rebound. Without evidence of a specific catalyst, attributing this gain to any particular business event would be speculation.

OCAC.WT

Ocean Capital Acquisition Corporation WT

$0.04+$0.00

+14.0%

JAGX

Jaguar Health IncHealthcare

$0.98+$0.12

+13.5%

NASDAQ · Mkt cap $4.5 M

Jaguar Health announced a Q2 2026 earnings webcast and 10-Q filing scheduled for August 19, likely triggering pre-earnings buying or short covering in this low-priced stock.

The only headline provided is Jaguar Health's announcement of an investor webcast on August 19 to discuss Q2 2026 financials and a Form 10-Q filing. The timing of this announcement on August 18, the day of the 13.51% gain, suggests the market reacted positively to the prospect of upcoming financial disclosure and management commentary. For a micro-cap stock trading below $1, anticipation of earnings and corporate updates can drive speculative positioning, short covering, or genuine investor interest in understanding the company's operational status. However, the headline does not disclose the actual earnings results, any guidance, or specific corporate developments—only that these will be discussed tomorrow. The move could also reflect general sentiment improvement, technical factors in a thinly traded name, or market positioning ahead of the webcast.

Biggest Losers

Tue, Aug 18, 2026 50

SHOT

Safety Shot IncFinancial Services

$0.93−$8.90

-90.5%

NASDAQ · Mkt cap $1.7 B

The provided news headline covers Bonk, Inc., not Safety Shot Inc. (SHOT), so the 90.53% single-day collapse appears unrelated to any disclosed earnings or corporate event in the available headlines.

The only news item provided is a Bonk, Inc. earnings report showing strong revenue growth and balance sheet improvement, which is unrelated to SHOT. This suggests the catastrophic 90% single-day drop in Safety Shot stock either stems from a company-specific event not captured in the provided headlines (such as failed clinical results, regulatory action, dilutive financing, insider selling, or management departure), a broader market or sector shock, or potentially a technical/liquidity event common in low-priced microcap stocks. Without access to SHOT-specific news from the snapshot date or prior day, the precise catalyst cannot be identified from the evidence on hand.

LGCL

Lucas GC LimitedTechnology

$0.24−$1.17

-82.9%

NASDAQ · Mkt cap $10 M

No news headlines were available in the last 48 hours to explain LGCL's massive 82.89% single-day drop, suggesting either a delayed market reaction to earlier events, a technical or liquidity event, or undisclosed company developments.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst. An 82.89% drop for any stock typically signals a material negative event such as earnings miss, guidance slash, regulatory action, delisting warning, or major insider departure. For micro-cap stocks trading at $0.24, liquidity constraints, reverse splits, dilution from secondary offerings, or bankruptcy concerns can also trigger severe declines. Without contemporaneous news, the move may reflect a delayed market response to information released earlier than the 48-hour window, a sudden loss of liquidity, or unconfirmed rumors circulating over-the-counter. The ranking as second-biggest loser suggests broader market awareness of the event, but the absence of news headlines on major financial platforms is unusual for a move of this magnitude and warrants direct inquiry into company filings or press releases.

SGLY

Singularity Future Technology Ltd.Industrials

$3.50−$3.22

-48.3%

NASDAQ · Mkt cap $2.7 M

Singularity announced an $1.8 million registered direct offering on August 18, which typically triggers shareholder dilution concerns and explains the 48% intraday collapse.

The company announced pricing of a registered direct offering for $1.8 million on the same day as the massive price drop. Registered direct offerings involve the issuance of new shares at a negotiated price, usually below current market value, to institutional or accredited investors. This mechanism causes immediate dilution to existing shareholders and signals potential financial stress or capital needs. The timing and magnitude of the decline align precisely with the announcement, suggesting the market repriced the stock downward upon learning of the offering terms. Without full details on the offering price per share or the investor composition, we cannot quantify the exact dilution percentage, but offerings of this structure routinely trigger 30-50% single-day declines in micro-cap and small-cap stocks, particularly those in logistics or technology where growth expectations are already fragile.

RDACR

Rising Dragon Acquisition Corp. Rights

$0.06−$0.03

-34.1%

NASDAQ

No news headlines were found in the last 48 hours to explain the 34% drop in RDACR, a SPAC rights offering that may have experienced a technical or market-driven sell-off typical of illiquid microcap securities.

The absence of any news in the last 48 hours makes it impossible to pinpoint a specific catalyst for the sharp 34% decline. RDACR is a rights offering from a special-purpose acquisition company, a security class characterized by low trading volume and high sensitivity to shifts in SPAC sentiment or broader market conditions. Plausible causes include: first, deterioration in SPAC market sentiment or negative headlines affecting the underlying sponsor or target company that circulated before the 48-hour window; second, technical or algorithmic selling in a thinly traded microcap security; third, expiration or exercise events related to the rights structure itself. Without contemporaneous news or volume data, the precise trigger remains unknown, though rights offerings are inherently volatile instruments subject to rapid repricing.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.08−$0.04

-33.4%

NASDAQ · Mkt cap $4.8 M

No news headlines are available in the last 48 hours to explain RITR's 33% drop, so the cause remains unclear; micro-cap stocks often experience sharp moves on thin trading volume, rumors, or delayed news from outside mainstream feeds.

The sharp 33% single-day decline in RITR has no corresponding headlines in the search results provided, making it impossible to tie the move to a specific corporate event, earnings announcement, regulatory action, or market catalyst. For a micro-cap stock trading at $0.08, several plausible categories of catalyst should be considered. First, news may have been released through channels not captured by Yahoo Finance RSS within the 48-hour window, or may have been announced after market hours or on a Thursday ahead of a Friday trading session. Second, micro-cap and penny stocks are particularly susceptible to technical selling, margin liquidations, or short squeeze reversals on light volume, which can amplify price swings. Third, if the company has outstanding debt or convertible securities, a covenant breach, refinancing event, or dilutive offering could trigger a sharp decline. Without headline corroboration, these remain hypotheses rather than established causes.

SNSC

SunScout Holding LimitedTechnology

$2.01−$0.99

-33.0%

NYSE

No financial headlines appeared in the last 48 hours for SNSC, so the 33% decline cannot be attributed to disclosed news. The drop likely reflects technical selling, a delayed market reaction to an earlier announcement, or sector-wide pressure.

The absence of recent news headlines creates a gap between the timing of the 33% single-day loss and any identifiable catalyst. For a small-cap or micro-cap stock like SNSC trading at $2.01, large intraday moves can be driven by several mechanisms: (1) delayed market reaction to an earnings miss, guidance cut, or financing event announced outside the headline window; (2) technical breakdown through a support level triggering algorithmic or stop-loss selling; (3) sector rotation or broad market weakness affecting lower-liquidity names disproportionately; or (4) undisclosed material developments that have not yet filtered into major news feeds. Without current headlines, we cannot pinpoint a specific catalyst, only identify the likely categories of cause.

DCGO

DocGo Inc.Healthcare

$0.48−$0.23

-32.8%

NASDAQ · Mkt cap $42 M

DocGo shares plummeted 32.83% after reporting Q2 earnings that missed expectations and provided a significantly wider loss forecast, despite an earlier headline suggesting an earnings beat.

The headline timeline reveals contradictory signals issued within hours on August 17. An initial 20:20 UTC announcement and 21:35 UTC headline claimed DocGo surpassed Q2 earnings estimates with a +500% earnings surprise. However, a subsequent 23:03 UTC earnings call highlights and the pre-market sell-off on August 18 indicate the market reacted negatively to the actual results and forward guidance. The Q2 revenue of $73.4 million represented a year-over-year decline from $80.4 million, driven by wind-down of migrant-related projects. The "significantly wider loss forecast" mentioned in the August 18 headline appears to be the primary driver of the sharp decline, as the market repriced the stock downward after absorbing both the revenue miss and deteriorating profitability outlook. The contradictory messaging suggests the initial earnings beat claim may have referred to EPS estimates narrowly, but underlying operational trends disappointed investors.

TRUG

TruGolf, Inc.Consumer Cyclical

$1.08−$0.53

-32.1%

NASDAQ · Mkt cap $1.2 M

No news headlines appeared in the last 48 hours, so the 32% drop cannot be attributed to a specific announced event. The decline may reflect technical selling, sector rotation, or delayed market reaction to an earlier announcement outside the news window.

TruGolf is a small-cap golf technology company trading at $1.08, and the absence of news in the last 48 hours means no earnings surprise, guidance revision, product announcement, or corporate action was publicly disclosed to explain the sharp move. For stocks in this market-cap range, large single-day declines often stem from technical factors such as stop-loss cascades, short covering reversals, or shifts in retail or institutional interest. Alternatively, the catalyst may have occurred outside the 48-hour news window and the market is still repricing. Without access to intraday volume data, social-media sentiment, or insider trading activity, we cannot determine whether this was forced selling tied to a margin call, a delayed reaction to earlier negative news, or a liquidity event in a thinly traded security.

AACBR

Artius II Acquisition Inc. Rights

$0.01−$0.01

-31.6%

NASDAQ

No news headlines were found in the last 48 hours to explain the 31.55% drop in AACBR rights. The decline likely reflects typical illiquidity and volatility in penny-priced SPAC rights, or a negative development in the parent acquisition.

AACBR is a rights offering tied to Artius II Acquisition Inc., a SPAC, and rights are inherently volatile securities with minimal trading volume. The absence of any news in the last 48 hours means the catalyst is either not yet reported by Yahoo Finance, occurred earlier, or is external to public headlines—such as a delay or failure in the SPAC's merger target negotiations, redemption announcements, or a broader loss of investor confidence in the deal. Rights often trade at steep discounts and experience outsized percentage moves on thin volume. Without a specific news headline to reference, the move appears driven by either illiquidity-driven technical selling or negative sentiment around the underlying SPAC transaction itself.

NCPL

Netcapital Inc.Financial Services

$0.22−$0.10

-31.0%

NASDAQ · Mkt cap $1.8 M

No news headlines were available in the last 48 hours to explain NCPL's 31% single-day drop, so the cause remains unclear without additional information about company-specific or market events.

The absence of any headlines in the Yahoo Finance RSS feed over the last two days means there is no documented news catalyst to point to for this sharp decline. NCPL is a micro-cap OTC-listed equity on NASDAQ, and stocks in this category can experience large intraday moves driven by several untracked mechanisms: technical selling or short covering reversals, delayed disclosure of negative developments not yet picked up by major news wires, retail trading flows or social media activity, broker-dealer actions, or shifts in liquidity conditions. Without access to company filings, press releases, or real-time market depth data, it is not possible to determine whether the drop reflects fundamental news, technical factors, or other market dynamics. The stock's position as a top-ten loser suggests broad-market participation in the sell-off, which could indicate a sector or sentiment shift rather than company-specific news.

OSRH

Bellevue Life Sciences Acquisition Corp.Healthcare

$0.41−$0.18

-30.9%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours to explain the 30.87% drop in OSRH stock, making the cause unclear without additional market context or company updates.

Bellevue Life Sciences Acquisition Corp. is a SPAC with minimal public trading activity and wide bid-ask spreads typical of blank-check companies. The complete absence of news in the past 48 hours combined with a severe single-day decline suggests several possible categories of cause: a delayed announcement of merger terms or termination that became public before news aggregators caught it, a redemption or capital event affecting share value, insider activity, technical delisting risk, or shift in redemption expectations. SPACs are particularly sensitive to rumor and deal-stage risk. Without headlines or filings, the specific catalyst remains speculative.

ZTG

Zenta Group Company LimitedIndustrials

$1.95−$0.90

-30.3%

NASDAQ · Mkt cap $30 M

ZTG fell 30.34% on August 18, 2026, but no news headlines were found in the prior 48 hours, so the precise trigger is unknown; the drop likely reflects either delayed market reaction to an earlier announcement, a technical sell-off, or an undisclosed corporate event.

The absence of any news headlines in the 48 hours preceding this substantial 30% single-day decline makes it impossible to identify a specific catalyst from publicly available sources. The magnitude of the move suggests a material negative event rather than pure technical selling. Possible explanations include a delayed market reaction to news released before the 48-hour window, an earnings disappointment or guidance cut announced after market close on a prior day, an insider transaction or SEC filing disclosing concerning information, or a rumor affecting investor sentiment. Without access to intraday news, earnings calendars, or SEC filings from the relevant period, attribution remains speculative. The rank as the 12th biggest loser suggests sector-wide pressure is unlikely; this appears stock-specific.

SNYR

Synergy CHC Corp.Healthcare

$0.11−$0.04

-29.2%

NASDAQ · Mkt cap $1.6 M

SNYR dropped 29% with no news headlines in the last 48 hours, suggesting the move was driven by technical selling, a delayed announcement, or an untracked event outside the news feed monitored here.

No recent news headlines were found in the last 48 hours to explain the 29% single-day decline. At a price of $0.11, SNYR appears to be a micro-cap or penny stock, a category prone to outsized moves on minimal catalysts or low volume. The most likely drivers of such a sharp drop in the absence of public news would be technical capitulation (support break, margin call cascade), delayed or untracked company announcements not yet indexed by major feeds, insider selling, or sector-wide contagion if the company operates in a currently distressed industry. Without access to real-time intraday volume, halt data, or regulatory filings from the snapshot date, the specific trigger remains unclear. The absence of coverage itself may indicate limited analyst following typical of micro-cap stocks.

WYFI

WhiteFiber, Inc.Technology

$27.05−$8.61

-28.7%

NASDAQ · Mkt cap $730 M

WhiteFiber announced a $250 million convertible debt offering on the same day it secured a major Krambu partnership and North Carolina site acquisition, likely triggering shareholder dilution concerns that outweighed the positive operational news.

WhiteFiber's 28.69% drop occurred despite what appears to be genuinely bullish developments: a $60 million North Carolina data center acquisition, analyst upgrade to $41 target, and an exclusive partnership with Krambu for a 100MW GPU buildout. However, the $250 million convertible senior notes announcement posted at market close (20:01 UTC) on 2026-08-18 likely catalyzed the sharp decline. Convertible offerings typically dilute existing shareholders and signal capital pressure, even when the underlying business wins are solid. The timing—bundling dilutive debt news with positive operational announcements—may have created negative sentiment that overshadowed the partnership and acquisition upside. Investor focus appears to have shifted from growth potential to immediate dilution risk.

SPEGR

Silver Pegasus Acquisition Corp Rights.

$0.17−$0.06

-26.0%

NASDAQ

No headlines were published in the last 48 hours explaining the 26% drop in SPEGR, a SPAC rights instrument. The decline likely reflects either broader market weakness in blank-check securities or a specific corporate action update not yet captured in the news feed.

Silver Pegasus Acquisition Corp Rights is a specialized instrument tied to a blank-check company, whose price movements are often driven by SPAC-specific catalysts: changes in merger negotiations, extension votes, redemption pressure, or deadline expirations. The absence of any news in the last 48 hours creates ambiguity. However, SPAC rights can trade very thinly and are sensitive to both parent company developments and shifts in investor appetite for blank-check vehicles. The magnitude of the decline (ranked 15th biggest loser) suggests a material event, but without headlines it could be a delayed announcement, a technical delisting risk signal, or an adverse vote outcome that hasn't yet propagated through the news cycle. Low liquidity in rights instruments can also amplify price swings on modest volume.

NOMA

NOMADAR Corp.Consumer Cyclical

$2.16−$0.74

-25.7%

NASDAQ · Mkt cap $38 M

No news headlines were found in the last 48 hours to explain NOMA's 25.66% drop, making the cause uncertain without access to intraday developments or market data beyond headlines.

The absence of any recent news coverage is notable given the stock's ranking as the 16th biggest loser of the day. This could indicate several scenarios: a delayed news pickup by Yahoo Finance RSS, an intraday market-moving event not yet widely reported, insider trading activity, a broader sector decline, or technical selling pressure. Smaller-cap stocks like NOMA often experience sharp moves on limited volume or sentiment shifts that may not immediately generate press coverage. Without knowing the company's business model, recent performance, or any corporate actions, it is difficult to pinpoint whether this is a fundamental catalyst, technical breakdown, or sentiment-driven selling. The lack of news does not rule out a real event; it simply means that event has not been captured in the available headline feed.

AIFU

Fanhua Inc.Financial Services

$13.75−$4.74

-25.6%

NASDAQ · Mkt cap $74 M

No news headlines were published in the last 48 hours for AIFU, so the 25.64% drop cannot be attributed to a specific announced catalyst and likely reflects either a delayed market reaction to an earlier event, technical selling, or an untracked development.

The absence of any Yahoo Finance headlines in the last two days is a significant constraint on causal inference. AIFU is a Chinese financial services and education company traded on NASDAQ, a sector and geography combination that can experience sharp moves from regulatory announcements, currency fluctuations, or sentiment shifts that may not be immediately picked up by major RSS feeds or may originate from non-English sources. A drop of this magnitude typically corresponds to earnings misses, guidance reductions, regulatory concerns, or macroeconomic shifts affecting the fintech or Chinese ADR space broadly. Without headline evidence, the move could reflect news that has not yet been indexed, a technical or algorithmic trigger, or developments reported only in Chinese-language outlets or company filings not yet syndicated to major Western financial news aggregators.

CBRG

Chain Bridge IFinancial Services

$4.47−$1.53

-25.5%

DAIC

CID HoldCo, Inc.Technology

$0.63−$0.13

-24.8%

NASDAQ · Mkt cap $508 K

No news headlines were found in the last 48 hours, so the 24.83% drop cannot be directly attributed to a published announcement or event. The decline likely reflects technical selling, a delayed market reaction to earlier news, or a sector-specific downturn affecting micro-cap stocks.

Yahoo Finance returned zero news articles for DAIC in the past 48 hours, which means no major corporate announcements, earnings results, regulatory actions, or acquisition news can be identified as the direct trigger. For a micro-cap stock trading at $0.63, price swings of this magnitude are not uncommon due to lower liquidity and wider bid-ask spreads. The drop could stem from several categories: a delayed market reaction to an older announcement that didn't immediately move the stock, technical or algorithmic selling after a recent high, sector rotation out of smaller-cap equities, short-seller activity, or simple illiquidity amplifying a modest change in demand. Without contemporaneous news, any explanation remains speculative.

SKYH.WT

Sky Harbour Group Corporation

$0.20−$0.07

-24.8%

MYSZ

My Size IncConsumer Cyclical

$2.28−$0.75

-24.8%

NASDAQ · Mkt cap $1.7 M

MySize stock fell 24.75% today despite the company announcing a positive milestone: its Naiz Fit platform surpassed 500 million size recommendations. The disconnect between bullish news and sharp selling suggests either market skepticism about the milestone's business impact or a separate negativ…

The two headlines published today both celebrate the same achievement—Naiz Fit crossing 500 million cumulative size recommendations and expanding into virtual try-on capabilities. On their face, these are developmental milestones that the company framed positively. However, the severe 24.75% drop the same day indicates the market either interpreted this news as disappointing relative to expectations, viewed the milestone as less commercially meaningful than management suggested, or is reacting to a different catalyst entirely. For a micro-cap AI fashion-tech stock like MySize, common catalysts for sharp declines include: margin pressure signals, slower-than-expected customer adoption despite headline metrics, dilutive financing announcements, or shifts in investor sentiment toward unprofitable AI firms. The positive framing of the 500 million figure makes it unlikely the market soured on the actual news; more probable is that either investors questioned revenue implications or an unlisted event (shareholder update, insider trading, sector rotation, or debt/equity concern) drove the selling.

BRUNW

Boost Run Inc. Warrant

$8.63−$2.79

-24.6%

FAMI

Farmmi IncConsumer Defensive

$0.10−$0.03

-24.2%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 24% drop likely reflects either a delayed market reaction to an untracked event, technical selling pressure, or a micro-cap liquidity event typical of penny stocks.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for FAMI's 24% single-day decline. Farmmi is a small-cap food processing company traded on NASDAQ, and securities in this category often experience sharp moves driven by factors that may not generate immediate press coverage. Possible explanations include delayed reaction to an earnings miss or guidance cut released outside the news feed window, a technical breakdown after a period of accumulation, sector-wide selling pressure affecting small-cap food stocks, or a liquidity-driven move typical of stocks trading under $1. Without corroborating news or filings, attributing the decline to any specific operational event would be speculation. Investors should check recent SEC filings and the company's investor relations page for context.

AIB

AIB Acquisition CorporationTechnology

$1.25−$0.40

-24.2%

KLAR

Klarna Group plcTechnology

$15.06−$4.50

-22.9%

DMIIR

Drugs Made In America Acquisition II Corp. Right

$0.07−$0.02

-22.4%

NASDAQ

No news headlines are available from the past 48 hours, so the cause of the 22.43% drop cannot be directly identified from public announcements. The decline likely reflects SPAC liquidation pressure, redemptions, or technical selling in a low-liquidity rights offering.

DMIIR is a SPAC rights unit trading at $0.07, a security class prone to sharp moves on low volume and limited public information flow. The absence of any news headlines in the past 48 hours does not rule out overnight developments in regulatory filings, redemption notices, or sponsor actions that may not immediately surface in broad RSS feeds. Rights offerings, particularly those approaching or past redemption deadlines or merger termination events, can experience sudden repricing as market makers adjust spreads or holders liquidate positions ahead of key dates. Without access to SEC filings or press releases issued directly by the issuer, the specific catalyst remains unknown, though SPAC-related structural factors (merger failure risk, shareholder redemption waves, or dilution from financing events) are typical drivers of such declines in this security class.

ONTX

Onconova Therapeutics IncFinancial Services

$20.28−$5.45

-21.2%

FNGR

FingerMotion, Inc.Communication Services

$0.24−$0.06

-21.1%

NASDAQ · Mkt cap $14 M

FingerMotion announced a CFO appointment and completed a $500k acquisition of 9.9% stake in Lyken AI Computing on August 17, but the market sold off 21% the next day, suggesting investor skepticism about the deal structure, valuation, or capital allocation at a micro-cap level.

On August 17, FingerMotion announced two corporate actions: the appointment of Chris Polimeni as CFO and completion of an acquisition giving the company a 9.9% stake in Lyken AI Computing for $500,000 in FNGR shares. The transaction implies a $5 million equity valuation for Lyken based on the share consideration paid. While entry into the AI compute market could be viewed strategically, the timing and structure may have triggered concern among shareholders. At micro-cap valuations, dilutive share issuances and acquisitions of minority stakes in private companies often face skepticism, particularly if the underlying rationale or synergies are unclear. The sharp 21% sell-off the following day suggests the market either saw the deal as overpriced, viewed the capital allocation as poor, or questioned management execution under the new CFO regime. Without commentary from the company on strategic rationale or profitability impact, exact motivation remains unclear.

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$10.85−$2.88

-21.0%

NASDAQ · Mkt cap $6.8 M

DBGI dropped 21% with no news headlines in the last 48 hours, making the specific catalyst unclear; the move may reflect technical selling, delayed negative developments, or broader sector weakness.

The absence of any news headlines in Yahoo Finance's last 48-hour feed makes it impossible to identify a confirmed catalyst for the 20.98% single-day decline. This is a material gap in evidence. For a mid-cap consumer brand company like Digital Brands Group, typical drivers of sharp drops include quarterly earnings misses, covenant violations or credit concerns, executive departures, product recalls, or significant customer losses. Without headlines, reasonable hypotheses center on either (a) delayed market pricing of information released outside the last 48 hours, (b) technical or algorithmic selling following a resistance break, or (c) a negative announcement made after market hours or through channels not yet syndicated to Yahoo Finance. The lack of visibility into what caused rank 29 on the losers list is itself notable and suggests either an information lag or an event not yet widely reported.

LTCH

Latch, Inc.Technology

$0.15−$0.04

-20.8%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours to explain LTCH's 20.79% drop, so the decline likely stems from technical selling, a delayed announcement, or broader sector weakness affecting the access-control or smart-lock industry.

The absence of any Yahoo Finance headlines in the past two days makes it difficult to pinpoint a specific catalyst for Latch's sharp decline. Latch is a provider of smart access and intercom solutions for multifamily buildings, a sector sensitive to real estate sentiment, interest rates, and developer spending cycles. A stock trading at $0.15 with this magnitude of intraday loss suggests either technical selling pressure driven by accumulated bad sentiment, a material announcement not yet broadly indexed by RSS feeds, or deterioration in the broader real estate or commercial technology environment. Without confirmed news, the most likely explanations are sector headwinds, execution concerns on the business side, or overnight developments not yet captured by major financial news sources.

SCKT

Socket Mobile IncTechnology

$0.73−$0.19

-20.3%

NASDAQ · Mkt cap $5.6 M

No headlines were found in the last 48 hours to explain Socket Mobile's 20.33% drop on August 18, 2026. The cause remains unclear from available news sources.

Socket Mobile is a small-cap mobile computing and barcode scanning hardware company, and a 20% single-day decline without accompanying news headlines suggests the move may be driven by factors outside traditional newswire coverage. Possible explanations for this type of stock include technical selling pressure from options expiration or forced liquidations, a delayed or embargoed announcement not yet picked up by Yahoo Finance RSS feeds, insider activity, or sector-wide weakness in mobile device or hardware stocks that may not generate individual company headlines. Small-cap stocks are also prone to low-volume moves that can exaggerate percentage swings. Without concrete news, the underlying cause cannot be determined from the evidence available.

FabrinetTechnology

$482.59−$116.51

-19.4%

NYSE · Mkt cap $14 B

Fabrinet crushed earnings and revenue expectations with record data center growth, but the stock fell 19.45% because investors focused on margin compression, disappointing free cash flow, and broader AI spending concerns that hit the entire optical and semiconductor complex.

The headlines establish that Fabrinet posted a record Q4 with revenue of $1.316 billion (up 45% year-over-year), data center sales surging 68%, and earnings that beat estimates by 6.49%. On the surface this is excellent. However, multiple sources explicitly state that investors "looked beyond stronger-than-expected revenue and earnings and focused instead on weaker margins, negative free cash flow," and that management guidance or forward commentary raised concerns about profitability despite top-line strength. Additionally, the broader optics sector declined simultaneously on separate news about AI spending trends (Anthropic reporting, WSJ article on AI capex), suggesting a sector-wide repricing of AI infrastructure demand expectations. The sell-off appears driven by both company-specific operational deterioration (margins, cash) and correlated sector weakness rather than a single miss.

RAM

Aries I Acquisition CorporationFinancial Services

$12.04−$2.85

-19.4%

LZB

La-Z-Boy IncConsumer Cyclical

$40.83−$8.02

-19.3%

NYSE · Mkt cap $1.3 B

La-Z-Boy reported first-quarter earnings that missed expectations due to uneven consumer demand, prompting a 19.3% single-day sell-off as the stock is among today's biggest losers.

The headline "La-Z-Boy stock plunges as 'uneven consumer' leads to earnings miss" establishes that the company reported quarterly results on 2026-08-18 that fell short of analyst expectations. The phrase "uneven consumer" signals weakness in demand across La-Z-Boy's customer base, a material concern for a furniture retailer dependent on discretionary spending. While a separate headline notes "positive written same-store sales," the earnings miss and cited consumer softness appear to have outweighed that bright spot in investor sentiment. The magnitude of the decline (19.3%) reflects a significant repricing of the stock following the report. No forward guidance revision or specific margin deterioration is detailed in the headlines provided, but the earnings disappointment combined with a narrative of demand weakness likely drove institutional and retail selling pressure.

ELWT

Elauwit Connection, Inc.Communication Services

$6.89−$1.66

-19.2%

NASDAQ · Mkt cap $50 M

Elauwit Connection fell 19% despite reporting record contracted units growth because Q2 revenue collapsed 46% year-over-year, revealing a significant gap between forward bookings and current cash generation that spooked investors.

The earnings report released on 2026-08-18 presents a classic growth-versus-profitability disconnect. The company achieved record contracted units growth of 33% year-over-year and 16% sequentially, with activated units up 94% and billed units up 163% on a year-over-year basis. These metrics signal strong future revenue potential and management highlighted 37 properties with over 10,000 new units signed year-to-date. However, the immediate headline from the same earnings day was a 46% year-over-year decline in Q2 revenue itself, attributed to timing of construction projects. For a growth company, investors often tolerate near-term revenue pressure if visibility is clear. Here, the scale of the revenue decline apparently exceeded market tolerance, likely because it raises questions about when those contracted units will actually convert to cash and whether the company needs additional capital to fund growth while current cash generation deteriorates. The market appears to have repriced the stock based on the harsh current-quarter reality outweighing the rosy forward indicators.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.06−$0.01

-18.7%

NASDAQ · Mkt cap $5.5 M

No relevant news headlines were found in the last 48 hours, so the 18.67% decline cannot be directly attributed to a disclosed event; the drop likely reflects either technical selling pressure, broader biotech weakness, or an undisclosed development.

The absence of any Yahoo Finance headlines in the 48 hours preceding this sharp 18.67% decline is notable. For a small-cap pharmaceutical stock trading at $0.06, moves of this magnitude are often driven by clinical trial results, regulatory decisions, financing announcements, or insider transactions. Given that Hepion is a development-stage biotech with limited commercial revenue, the stock is vulnerable to sentiment shifts tied to pipeline progress, cash burn concerns, or dilutive financing rounds. Without a disclosed catalyst in the news feed, the decline could reflect a leaked development, technical breakdown below a key support level, or a delayed announcement that has not yet reached the Yahoo Finance RSS. Small-cap biotechs occasionally experience sharp reversals on rumors or incomplete information that precedes formal press releases.

MRCY

Mercury Systems IncIndustrials

$105.00−$21.67

-18.7%

NASDAQ · Mkt cap $5.1 B

Mercury Systems reported strong Q2 earnings that beat revenue expectations and posted record bookings and backlog, yet the stock fell 18.65%, suggesting the market's positive reaction to the headline results masked either weak forward guidance, margin concerns, or a valuation reset despite operat…

The headlines establish that Mercury Systems delivered upbeat Q2 results with revenue of $289.8 million (up 6.1% year-over-year), topped consensus expectations, and achieved record Q4 bookings of $660 million (up 93.1% YoY) with a record backlog exceeding $1.9 billion and a strong book-to-bill ratio of 2.28. Despite these operational achievements, the stock dropped sharply on the day of the earnings announcement. This is a classic earnings paradox: strong headline numbers paired with a sharp decline typically reflect either disappointing forward guidance, deteriorating profitability metrics not highlighted in the revenue-focused headlines, management commentary that tempered near-term expectations, or a valuation compression as the market reprices a stock that had run up ahead of results. The non-GAAP EPS of $0.37 is mentioned but not contextualized against expectations, leaving open the possibility that margin compression or a slower-than-expected profit trajectory drove the sell-off despite revenue outperformance.

BIVI

BioVie Inc.Healthcare

$0.97−$0.22

-18.2%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 18% drop likely reflects either a delayed market reaction to an earlier announcement, a broad sector sell-off, or trading in a highly volatile micro-cap stock with low liquidity.

BioVie is a small-cap biotech company, and the absence of any news in the provided headlines means we cannot point to a specific catalyst for today's decline. However, biotech stocks in this market-cap range are characteristically volatile and susceptible to several broad pressures: clinical trial setbacks or announcements released outside the 48-hour window, sector-wide biotech weakness, changes in funding sentiment, or technical selling in a stock with limited float and trading volume. The magnitude of the loss (18%) is significant but not extraordinary for a micro-cap biotech. Without access to pre-market news, insider trading, clinical trial databases, or regulatory filings released before the snapshot date, attribution remains speculative. The most likely categories of cause are clinical, funding-related, or technical rather than general market factors.

SKYE

Skye Bioscience, Inc.Healthcare

$0.35−$0.08

-17.9%

NASDAQ · Mkt cap $13 M

Skye Bioscience announced a merger with Redx Pharma creating a fibrosis-focused company where shareholders receive only a 5.4% stake, indicating significant dilution and loss of control that triggered the 17.86% sell-off.

The earnings call highlights reveal a strategic pivot through a merger that explicitly offers Skye shareholders just a 5.4% stake in the combined entity plus a contingent value right on Nimacimab monetization. This structuring implies substantial dilution of existing ownership and reduced control in the post-merger company. For small biotech shareholders, such an unfavorable equity stake in a merger typically signals either desperation to find a partner, weak negotiating position, or that the standalone company was deemed non-viable. The announcement appears to have been made on August 17th, and the stock declined 17.86% by market close on August 18th. The contingent value right adds some upside potential, but the core message of minimal ownership retention in a merged entity usually triggers immediate sell-offs as investors exit ahead of dilution.

AVCO

Avalon GloboCare Corp

$0.18−$0.04

-17.7%

THCH

TH International LimitedConsumer Cyclical

$1.40−$0.30

-17.6%

NASDAQ · Mkt cap $54 M

TH International (Tims China) reported a 21.7% revenue decline in Q2 2026 with falling comparable-store transactions and underperforming store closures, triggering the 17.65% stock drop on earnings day.

The company announced Q2 2026 financial results on August 18, 2026, disclosing a material 21.7% revenue contraction alongside declines in system sales and comparable-store transaction counts. The headlines indicate store underperformance necessitated closures and that delivery-platform subsidy costs pressured results. While management framed a $55 million financing package and strategic initiatives around product innovation and store optimization as forward-looking positives, the headline numbers—a steep revenue drop in a competitive quick-service restaurant market—clearly disappointed investors. The stock's ranking as the 41st biggest loser suggests broad-based selling pressure on the back of these operational headwinds.

IVF

NAYA Biosciences, Inc.Healthcare

$1.39−$0.30

-17.2%

NASDAQ · Mkt cap $2.0 M

IVF reported strong Q2 earnings with 17% revenue growth and improved clinic profitability on August 17, yet the stock fell 17.24% the next day, suggesting market disappointment with forward guidance, margins, or valuation despite the headline beat.

The recent news establishes that INVO Fertility delivered solid operational results: Q2 revenue climbed 17% to $2.18 million, the Family Beginnings acquisition contributed a full quarter, and the clinic platform achieved positive Adjusted EBITDA. These facts are straightforward wins. However, the 17% one-day drop on August 18 following the August 17 earnings release indicates the market reacted negatively overall. This disconnect between positive revenue and profitability metrics and the sharp sell-off suggests investors were likely disappointed by earnings guidance for future quarters, margin compression concerns, cash burn trajectory, or a valuation reset after the stock had perhaps run up before the report. The news provided does not include forward guidance, net income figures, or management commentary that would explain the bearish reaction, leaving the specific disappointment unidentified.

KEEL

Keel Infrastructure Corp.Technology

$3.17−$0.64

-16.7%

NASDAQ · Mkt cap $2.0 B

No news headlines were published in the last 48 hours regarding KEEL, so the 16.71% single-day drop cannot be directly attributed to a disclosed catalyst; the decline likely reflects technical selling, market-wide pressure, or undisclosed company-specific developments.

The absence of any recent news headlines in the Yahoo Finance RSS feed for KEEL over the past 48 hours makes it impossible to pinpoint a specific disclosed catalyst for the sharp 16.71% decline. For a company like Keel Infrastructure Corp., typical drivers of single-day moves of this magnitude would include earnings misses or guidance cuts, delays or cancellations of infrastructure contracts, changes in management or board composition, or shifts in sector sentiment. Alternatively, the move could reflect technical factors such as options expiration, a liquidity event, heavy institutional redemption, or accumulated selling pressure from prior negative sentiment. Without concrete news, we cannot distinguish between these possibilities. The stock's ranking as the 43rd biggest loser suggests sector-wide pressure is unlikely to be the sole driver.

MLEC

MOOLEC SCIENCE SAHealthcare

$7.16−$1.41

-16.5%

NASDAQ · Mkt cap $5.0 M

No news headlines were published in the last 48 hours, so the 16.46% drop cannot be attributed to a specific identifiable catalyst; the move likely reflects technical selling, sector weakness, or an untracked announcement.

MLEC experienced a sharp 16.46% decline on August 18, 2026, ranking as the 44th biggest loser of the day, yet no news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This absence of reported catalysts makes it difficult to pinpoint a specific cause. For a biotech or agricultural-biotech company like MOOLEC Science, typical triggers for single-day double-digit declines include unfavorable clinical or regulatory results, downward analyst revisions, insider selling, cash burn concerns, or clinical trial setbacks. Without access to earnings reports, regulatory filings, or company announcements posted outside the RSS feed, the precise cause remains unclear. The drop could also reflect broader market weakness in the biotech sector, technical breakdown of support levels, or delayed news dissemination to RSS feeds.

LJAQ

LightJump Acquisition Corporation

$7.16−$1.41

-16.5%

RKDA

Arcadia Biosciences IncConsumer Defensive

$0.41−$0.08

-16.1%

NASDAQ · Mkt cap $964 K

No news headlines were found in the last 48 hours to explain the 16% drop in RKDA stock, so the cause remains unclear from publicly available information.

Arcadia Biosciences experienced a significant intraday decline with no corresponding news coverage in the most recent headlines. This absence of obvious catalyst makes determination of cause difficult. For small-cap biotech stocks like RKDA, typical drivers of sharp single-day moves include clinical trial results announcements, regulatory decisions, earnings misses, insider transactions, or shifts in sector sentiment. Alternatively, the decline could reflect technical selling pressure, a delayed market reaction to news released outside the 48-hour window, or stock-specific developments not yet covered by major news outlets. Without access to intraday volume data or company filings, attributing the move to any specific event remains speculative.

BITF

Bitfarms Ltd.Financial Services

$3.17−$0.61

-16.0%

NASDAQ · Mkt cap $2.1 B

No news headlines were found in the last 48 hours to explain BITF's 16% drop, so the cause remains unclear; the decline could reflect broader crypto market weakness, Bitcoin mining economics, or delayed market reaction to an earlier event.

The absence of any news in the last two days makes a direct headline-driven explanation impossible. Bitfarms is a Bitcoin mining company, so its stock is sensitive to Bitcoin price movements, mining difficulty adjustments, and power costs. A 16% single-day drop without accompanying news could reflect a sharp Bitcoin price decline that occurred outside the news feed window, deterioration in mining margins, sector rotation out of crypto-related equities, or a delayed market repricing following an event announced more than 48 hours ago. Without access to Bitcoin's price action on 2026-08-18 or earlier press releases, the specific trigger cannot be identified from the evidence provided.

AAOI

Applied Optoelectronics IncTechnology

$131.43−$24.76

-15.9%

NASDAQ · Mkt cap $8.9 B

Applied Optoelectronics fell 15.9% despite positive headlines about AI data center demand and U.S. laser manufacturing capabilities, suggesting the sell-off was driven by broader market dynamics or an unannounced event rather than the news provided.

The two recent headlines both frame AAOI positively: the first highlights the company's positioning for AI-driven optical networking growth as demand for data center optics rises, and the second emphasizes management's confidence in U.S.-based laser production capabilities as a competitive advantage. Neither headline contains negative information, earnings misses, guidance cuts, or adverse developments. The 15.9% single-day loss ranks AAOI among the top 50 losers on the NASDAQ, which suggests a material catalyst. Given the absence of company-specific negative news in the provided headlines, the decline is more likely attributable to sector rotation away from semiconductor or optical equipment suppliers, a broader market correction, profit-taking after a recent run-up, or an unannounced event not yet reflected in the Yahoo Finance RSS feed. Without access to intraday volume, short-squeezes, or breaking news beyond the provided window, the root cause remains speculative.

CHGA

Change Agents CorporationReal Estate

$0.18−$0.03

-15.9%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours, so the 15.88% drop cannot be attributed to a reported event; the decline likely reflects either broad market pressure on micro-cap stocks, technical selling, or undisclosed company-specific developments.

Yahoo Finance returned zero headlines for CHGA in the past 48 hours, so no specific catalyst can be identified from public announcements. The stock trades at $0.18 and ranks among the day's fifty biggest losers by percentage, suggesting either a sharp intraday selloff or sustained weakness in a highly volatile micro-cap name. Penny stocks and ultra-low-priced equities are typically sensitive to liquidity events, short-covering reversals, options expiry, sector rotation, or retail trading momentum shifts. Without earnings, guidance, regulatory action, or M&A news in the provided headlines, the driver remains opaque. It is also possible that news exists but was not captured by the RSS feed, or that the move is purely technical or based on private communications not yet reflected in major news outlets.

XTIA

XTI Aerospace, Inc.Industrials

$1.33−$0.25

-15.9%

NASDAQ · Mkt cap $51 M

XTI Aerospace announced an executive leadership transition on August 18th, triggering a 15.87% single-day drop, likely signaling investor concern about management stability or strategic uncertainty at the aerospace/drone company.

The headline confirms an executive leadership transition was announced on the day of the decline, which is a material corporate event that commonly triggers sell-offs as investors reassess management competence, strategic direction, or operational continuity. The news snippet is truncated and does not provide details on who departed, who was promoted, or the circumstances, leaving key context missing. Leadership changes at smaller aerospace firms can be particularly sensitive given the technical complexity and regulatory requirements of the industry, and the reliance on key personnel relationships. However, without the full announcement text it is impossible to determine whether this was a planned succession, a forced departure, or a routine rotation. The scale of the decline (15.87%) suggests the market viewed this negatively, but the specific reason requires access to the complete press release or investor commentary.